HOTH
Hoth Therapeutics, Inc.
Key Financials
Revenue
$1.2B
N/A
Net Income
$-12469302
↓ 52.3%
EPS (Diluted)
$-0.90
↑ 29.7%
Cash & Equivalents
$6.2M
↓ 11.2%
Total Liabilities
$1.5M
↑ 74.2%
Shareholders' Equity
$6.2M
↓ 10.6%
Operating Cash Flow
$-9803918.00
↓ 40.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| 8-K | 4/16/2026 | View on SEC |
| 424B5 | 4/16/2026 | View on SEC |
| 8-K | 4/2/2026 | View on SEC |
| 424B5 | 4/2/2026 | View on SEC |
| 10-K | 3/27/2026 | View on SEC |
| 8-K | 1/16/2026 | View on SEC |
| EFFECT | 12/4/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HOTH |
| Company Name | Hoth Therapeutics, Inc. |
| CIK | 1711786 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (646)756-2997 |